You are currently viewing a new version of our website. To view the old version click .

Biomedicines, Volume 12, Issue 7

July 2024 - 249 articles

Cover Story: EGFR tyrosine kinase inhibitors (TKIs) are key drugs in the treatment of non-small cell lung cancer patients with EGFR-activating mutations. First-, second-, and third-generation (abbreviated as 1G, 2G, and 3G) EGFR-TKIs have been applied in clinical use, and osimertinib (3G-TKI) is now the standard-of-care as front-line treatment in many countries. In this study, we searched for an optimal TKI after front-line osimertinib failure using in vitro models harboring EGFR-activating mutation plus osimertinib-resistant secondary mutation by comparing erlotinib (1G-TKI), novel 3G-TKIs, and BI4020 (4G-TKI). We also explored acquired resistance mechanisms to BI4020 assuming that it may be used as a front-line TKI in the near future. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (249)

  • Article
  • Open Access
13 Citations
3,573 Views
20 Pages

Background: Recent studies have demonstrated that the migrasome, a newly functional extracellular vesicle, is potentially significant in the occurrence, progression, and diagnosis of cardiovascular diseases. Nonetheless, its diagnostic significance a...

  • Article
  • Open Access
3 Citations
2,587 Views
14 Pages

CRISPR-Cas System, Antimicrobial Resistance, and Enterococcus Genus—A Complicated Relationship

  • Carmen Costache,
  • Ioana Colosi,
  • Dan-Alexandru Toc,
  • Karla Daian,
  • David Damacus,
  • Alexandru Botan,
  • Adelina Toc,
  • Adrian Gabriel Pana,
  • Paul Panaitescu and
  • Vlad Neculicioiu
  • + 3 authors

(1) Background: The rise in antibiotic resistant bacteria poses a significant threat to public health worldwide, necessitating innovative solutions. This study explores the role of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) in...

  • Review
  • Open Access
12 Citations
6,522 Views
31 Pages

Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges

  • Antonio Cigliano,
  • Weiting Liao,
  • Giovanni A. Deiana,
  • Davide Rizzo,
  • Xin Chen and
  • Diego F. Calvisi

Hepatocellular carcinoma (HCC), the predominant primary liver tumor, remains one of the most lethal cancers worldwide, despite the advances in therapy in recent years. In addition to the traditional chemically and dietary-induced HCC models, a broad...

  • Article
  • Open Access
1 Citations
2,473 Views
10 Pages

Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid

  • Santina Quarta,
  • Michele Sandre,
  • Mariagrazia Ruvoletto,
  • Marta Campagnolo,
  • Aron Emmi,
  • Alessandra Biasiolo,
  • Patrizia Pontisso and
  • Angelo Antonini

In Parkinson’s disease, neuroinflammation is a double-edged sword; when inflammation occurs it can have harmful effects, despite its important role in battling infections and healing tissue. Once triggered by microglia, astrocytes acquire a rea...

  • Article
  • Open Access
3 Citations
2,590 Views
11 Pages

The Kinetics of Inflammation-Related Proteins and Cytokines in Children Undergoing CAR-T Cell Therapy—Are They Biomarkers of Therapy-Related Toxicities?

  • Paweł Marschollek,
  • Karolina Liszka,
  • Monika Mielcarek-Siedziuk,
  • Iwona Dachowska-Kałwak,
  • Natalia Haze,
  • Anna Panasiuk,
  • Igor Olejnik,
  • Tomasz Jarmoliński,
  • Jowita Frączkiewicz and
  • Zuzanna Gamrot
  • + 3 authors

CD19-targeted CAR-T cell therapy has revolutionized the treatment of relapsed/refractory (r/r) pre-B acute lymphoblastic leukemia (ALL). However, it can be associated with acute toxicities related to immune activation, particularly cytokine release s...

  • Article
  • Open Access
3 Citations
2,554 Views
18 Pages

Superior Anticancer and Antifungal Activities of New Sulfanyl-Substituted Niclosamide Derivatives

  • Jingyi Ma,
  • Dileepkumar Veeragoni,
  • Hindole Ghosh,
  • Nicole Mutter,
  • Gisele Barbosa,
  • Lauren Webster,
  • Rainer Schobert,
  • Wendy van de Sande,
  • Prasad Dandawate and
  • Bernhard Biersack

The approved anthelmintic salicylanilide drug niclosamide has shown promising anticancer and antimicrobial activities. In this study, new niclosamide derivatives with trifluoromethyl, trifluoromethylsulfanyl, and pentafluorosulfanyl substituents repl...

  • Article
  • Open Access
4 Citations
4,409 Views
19 Pages

This study investigates the effects of palmitoylethanolamide (PEA) on the gut microbiome of overweight adults. Fifty-eight participants (twenty males, thirty-eight females) aged 18–65 years with a BMI range of 30–40 kg/m2 were recruited....

  • Article
  • Open Access
5 Citations
2,303 Views
11 Pages

Developing a Polygenic Risk Score with Age and Sex to Identify High-Risk Myopia in Taiwan

  • Hui-Ju Lin,
  • Yu-Te Huang,
  • Wen-Ling Liao,
  • Yu-Chuen Huang,
  • Ya-Wen Chang,
  • Angel L. Weng and
  • Fuu-Jen Tsai

Myopia is the leading cause of impaired vision, and its prevalence is increasing among Asian populations. This study aimed to develop a polygenic risk score (PRS) followed by replication to predict myopia in the Taiwanese population. In total, 23,688...

  • Article
  • Open Access
1,435 Views
9 Pages

The Impact of Pentraxin 3 Serum Levels and Angiotensin-Converting Enzyme Polymorphism on Pulmonary Infiltrates and Mortality in COVID-19 Patients

  • Zdravka Krivdić Dupan,
  • Vlatka Periša,
  • Mirjana Suver Stević,
  • Martina Mihalj,
  • Maja Tolušić Levak,
  • Silva Guljaš,
  • Tamer Salha,
  • Domagoj Loinjak,
  • Martina Kos and
  • Matej Šapina
  • + 4 authors

Objectives: The aim of this study was to examine the impact of the pentraxin 3 (PTX3) serum level and angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism on the severity of radiographic pulmonary infiltrates and the clinica...

  • Review
  • Open Access
3 Citations
4,029 Views
11 Pages

The emergence of PARP inhibitors as a therapeutic strategy for tumors with high genomic instability, particularly those harboring BRCA mutations, has advanced cancer treatment. However, recent advances have illuminated a multifaceted role of PARP1 be...

of 25

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059